Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of 2 anti-SPARC antibodies to predict response to chemotherapy for pancreatic adenocarcinoma

Use of 2 anti-SPARC antibodies to predict response to chemotherapy for pancreatic adenocarcinoma

US Patent 9091697 · Granted Jul 28, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Peptides and nanoparticles for intracellular delivery of molecules2025
Methods of treating central nervous system disorders via administration of nanop2025
Methods of treating epithelioid cell tumors2024
Methods of assessing suitability of use of pharmaceutical compositions of albumi2024
Polypeptide-antibody complexes and uses thereof2024
Methods of treating central nervous system disorders via administration of nanop2024
Peptides and nanoparticles for intracellular delivery of molecules2023
Polypeptide-antibody complexes and uses thereof2022
Pharmaceutical compositions of albumin and rapamycin2022
Methods of assessing suitability of use of pharmaceutical compositions of albumi2022
Methods of treating epithelioid cell tumors comprising administering a compositi2021
Methods of assessing suitability of use of pharmaceutical compositions of albumi2021